MedImmune Licensee Standing Does not Apply to Portfolio License
by Dennis Crouch The Federal Circuit’s new decision in Apple Inc. v. Qualcomm Inc. (Fed. Cir. 2021) offers an interesting standing puzzle. After some heated litigation, Apple licensed 20,000+ Qualcomm patents as part of a six-year covenant-not-to-sue which resulted in the litigation being dismissed with prejudice. Meanwhile, the parallel inter partes reexaminations (IPRs) moved forward with regard … Continue reading MedImmune Licensee Standing Does not Apply to Portfolio License
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed